ImmunoPrecise Antibodies Ltd. (OTCMKTS:IPATF – Get Free Report) shares traded down 1% during trading on Wednesday . The company traded as low as $0.95 and last traded at $0.98. 28,607 shares were traded during trading, an increase of 41% from the average session volume of 20,327 shares. The stock had previously closed at $0.99.
ImmunoPrecise Antibodies Stock Performance
The business has a 50 day moving average of $1.09 and a 200 day moving average of $1.43.
ImmunoPrecise Antibodies Company Profile
ImmunoPrecise Antibodies Ltd. engages in the provision of human therapeutic antibody discovery and development services. It offers a selection of antibodies, enzymes, enzymes activity assays, arthritis animal products, proteins, deiminated proteins, and hybridoma licensing for research purposes. Its services include B cell sorting, screening and sequencing; custom, immune and naive phage display production and screening; bi-specific, tri-specific, VHH, and VNAR antibody manufacturing; antibody engineering; and antibody optimization and humanization.
Read More
- Five stocks we like better than ImmunoPrecise Antibodies
- How to Evaluate a Stock Before Buying
- This Stock’s Price Shifts Into High Gear With Analyst Upgrades
- Stock Market Sectors: What Are They and How Many Are There?
- AI Boosts Glass Tech Leader Stock: Shares Up 75% and More to Come
- Dividend Payout Ratio Calculator
- AI Partnership Boosts This Top Tech Stock: Ready for More Gains?
Receive News & Ratings for ImmunoPrecise Antibodies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmunoPrecise Antibodies and related companies with MarketBeat.com's FREE daily email newsletter.
